Stimulation of protein kinase C activity by compactin in vascular smooth muscle cells.
The effect of compactin (a lovastatin analogue) on vascular smooth muscle cells was studied at the level of cell proliferation and protein kinase C. It was observed: a) an inhibition of cell proliferation by compactin at a micromolar range, which was prevented by simultaneous addition of mevalonate; b) a stimulation of DNA synthesis with a shift in the cell cycle kinetics, either in the presence or absence of fetal calf serum and c) an increase in protein kinase C activity in compactin-treated cells in the G1 phase of the cycle. This increase was similar to the one elicited by calyculin A, an inhibitor of protein phosphatases of type PP-1 and PP-2A. It is suggested that compactin behaves as a PP-1/PP-2A protein phosphatase inhibitor, inhibiting proliferation of smooth muscle cells by a block of the cell cycle after the S-phase.
Latruffe
N
N
Institut für Biochemie und Molekularbiologie, Universität Bern, Switzerland.
Boscoboinik
D
D
Azzi
A
A
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000494:pharmacology; D008387:Marine Toxins; D008798:Mevalonic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000201:enzymology*; D010080:Oxazoles / Q000494:pharmacology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D011493:Protein Kinase C / Q000378:metabolism*; D051381:Rats
D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents; D008387:Marine Toxins; D010080:Oxazoles; C012258:mevastatin; C015367:mevalonolactone; C059041:calyculin A; D008148:Lovastatin; D011493:Protein Kinase C; D010749:Phosphoprotein Phosphatases; D008798:Mevalonic Acid